Fig. 2From: Cytoreductive prostatectomy improves survival outcomes in patients with oligometastases: a systematic meta-analysisForest plot corresponding to patient overall survival at 3 years (A) and 5 years (B) in the cytoreductive prostatectomy group and the androgen deprivation therapy group. No significant difference in OS was observed at 3 years (A) [OR = 1.73, 95% CI (0.83, 3.58), P = 0.14 > 0.05] or 5 years (B) [OR = 2.26, 95% CI (0.97, 5.28), P = 0.06 > 0.05]Back to article page